首页|期刊导航|海南医科大学学报|肝豆灵通过调控LncRNA H19促进胆汁排铜改善Wilson病肝纤维化

肝豆灵通过调控LncRNA H19促进胆汁排铜改善Wilson病肝纤维化OA

Gandouling ameliorates hepatic fibrosis in Wilson disease by regulating LncRNA H19 to promote biliary copper excretion

中文摘要英文摘要

目的:观察肝豆灵(Gandouling,GDL)对铜负荷Wilson病大鼠肝组织和血清外泌体长链非编码RNA H19(long non-coding RNA H19,LncRNA H19)及胆汁淤积的影响,探讨GDL改善Wilson病肝纤维化的作用机制.方法:将 60 只SD雄性大鼠随机分为正常(Control)组、模型(Model)组、GDL低剂量(GDL-L)组、GDL中剂量(GDL-M)组、GDL高剂量(GDL-H)组、青霉胺(penicillamine,PCA)组,每组10只.通过喂养五水合硫酸铜(CuSO4·5H2O)构建铜负荷Wilson病肝纤维化模型,造模过程中同时给药.GDL各治疗组及PCA组灌胃相应剂量药物,Control组和Model组灌胃等体积蒸馏水,连续30 d.H&E和Masson染色观察肝脏病理学改变;ELISA检测胆汁淤积指标γ-谷氨酰转移酶(γ-glutamyl transferase,GGT)、碱性磷酸酶(alkaline phosphatase,ALP)、总胆红素(total bilirubin,TBIL)、总胆汁酸(total bile acids,TBA)和肝功能指标丙氨酸氨基转移酶(alanine aminotransferase,ALT)、天冬氨酸氨基转移酶(aspartate aminotransferase,AST)水平;原子吸收分光光度计测定胆汁铜含量;RT-qPCR检测LncRNA H19、胆管反应指标细胞角蛋白 7(cytokeratin7,CK7)和细胞角蛋白 19(cytokeratin19,CK19)基因表达;Western blot观察CK7、CK19蛋白表达.结果:与Control组相比,Model组肝组织病理形态显示细胞核边界不清伴有裂解、坏死,肝组织中央静脉及胆管周围出现明显的胶原沉积;ALT、AST、GGT、ALP、TBIL、TBA、胆汁铜水平明显升高(P<0.01);LncRNA H19、CK7、CK19基因表达水平明显升高(P<0.01);CK7、CK19蛋白水平明显升高(P<0.01).经GDL和PCA干预后,肝组织纤维化程度明显改善;ALT、AST、GGT、ALP、TBIL、TBA、胆汁铜含量降低(GDL-L组ALT、TBIL、TBA除外)(P<0.01);LncRNA H19、CK7、CK19基因表达水平降低(P<0.01);CK7、CK19蛋白水平降低(GDL-L组CK7除外)(P<0.05).结论:GDL可能通过调控LncRNA H19的表达,促进胆汁排铜,改善铜负荷Wilson病大鼠肝纤维化.

Objective:To observe the effects of Gandouling(GDL)on hepatic and serum exosomal long non-coding RNA H19(LncRNA H19)as well as cholestasis in hepatic tissues of copper-loaded rats with Wilson disease,and to explore the mecha-nism of action of GDL ameliorating hepatic fibrosis in Wilson disease.Methods:A total of 60 SD male rats were randomly divided into the normal group(Control),the model group(Model),the GDL low-dose group(GDL-L),the GDL medium-dose group(GDL-M),the GDL high-dose group(GDL-H),and the penicillamine group(PCA),with 10 rats in each group.A copper-loaded Wilson disease liver fibrosis model was constructed by feeding copper(Ⅱ)sulfate pentahydrate(CuSO4·5H2O),and the drug was administered simultaneously during the modeling process.Each treatment group of GDL and the PCA group were administered the corresponding doses of the drugs by gavage,while the Control group and the Model group were administered an equal volume of distilled water by gavage for 30 consecutive days.H&E and Masson staining were used to observe the pathological changes in the liver.ELISA was utilized to measure cholestasis indicators,including γ-glutamyl transferase(GGT),alkaline phosphatase(ALP),total bilirubin(TBIL),and total bile acids(TBA),as well as liver function markers alanine aminotransferase(ALT)and aspartate aminotransferase(AST).Atomic absorption spectrophotometer was used to determine the copper content of bile.RT-qPCR was used to detect the gene expressions of LncRNA H19,cytokeratin 7(CK7),an indicator of bile duct response,and cytokeratin 19(CK19);Western blot was used to observe the protein expressions of CK7 and CK19.Results:Compared to the Control group,the histopathologic pattern of liver tissue in the Model group showed unclear cell nucleus boundaries with lysis and necrosis,and obvious collagen deposition around the central vein and bile ducts of the liver tissue;the levels of ALT,AST,GGT,ALP,TBIL,TBA,and biliary copper were elevated significantly(P<0.01).LncRNA H19,CK7,and CK19 gene ex-pression levels increased significantly(P<0.01).CK7 and CK19 protein levels increased significantly(P<0.01).The degree of hepatic tissue fibrosis was significantly improved after the intervention of GDL and PCA.ALT,AST,GGT,ALP,TBL,TBA,and biliary copper levels were decreased(except for ALT、TBIL and TBA in the GDL-L group)(P<0.01),LncRNA H19,CK7,and CK19 gene expression levels were decreased(P<0.01),and CK7 and CK19 protein levels were decreased(except for CK7 in the GDL-L group)(P<0.05).Conclusion:GDL may promote biliary copper excretion and ameliorate hepatic fibrosis in copper-loaded rats with Wilson disease by regulating the expression of LncRNA H19.

汪瀚;殷馨;花代平;孙兰婷;宣巧玉;纪美艳;杨文明

安徽中医药大学第一附属医院神经内科,安徽 合肥 230031||新安医学教育部重点实验室,安徽 合肥 230038安徽中医药大学第一临床医学院,安徽 合肥 230031安徽中医药大学第一附属医院神经内科,安徽 合肥 230031安徽中医药大学第一附属医院神经内科,安徽 合肥 230031安徽中医药大学第一附属医院神经内科,安徽 合肥 230031安徽中医药大学第一临床医学院,安徽 合肥 230031安徽中医药大学第一附属医院神经内科,安徽 合肥 230031||新安医学教育部重点实验室,安徽 合肥 230038

医药卫生

肝豆灵胆汁淤积肝纤维化LncRNA H19Wilson病

GandoulingCholestasisLiver fibrosisLncRNA H19Wilson disease

《海南医科大学学报》 2026 (5)

355-361,7

This study was supported by the Regional Innovation and Development Joint Fund of National Natural Science Foundation of China(U22A20366)Anhui Provincial Natural Science Foundation(2208085MH266)Anhui Health Research Program(AHWJ2022b036) 国家自然科学基金区域创新发展联合基金项目(U22A20366)安徽省自然科学基金项目(2208085MH266)安徽省卫生健康科研项目(AHWJ2022b036)

10.13210/j.cnki.jhmu.20250410.001

评论